SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing significant investor attention driven by a mix of recent defense contract wins, including work for the U.S. Army, and speculative excitement surrounding the upcoming SpaceX IPO. While the community is actively debating the stock's volatility and its long-term potential as a key piece of space infrastructure, many are viewing recent pullbacks as accumulation opportunities ahead of broader industry growth.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant volatility as investors digest earnings that, while showing robust AI-driven growth, failed to meet the market's exceptionally high expectations for raised forward guidance. The community is actively debating whether this pullback represents an overreaction by algorithms and short-term traders or a fundamental shift in the AI hardware investment thesis.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing significant volatility driven by intense retail interest and speculative trading following high-profile industry commentary regarding its potential for future growth. The community remains deeply divided, with bulls actively buying the dip to capitalize on anticipated S&P 500 inclusion and AI infrastructure momentum, while bears argue the stock is overextended and driven by hype rather than fundamental performance.

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Lifevantage Corporation

Lifevantage Corporation is currently the focus of significant community interest as investors track a high-conviction short squeeze setup, fueled by extremely high cost-to-borrow fees and limited share availability. Market participants are debating the potential for an explosive upside move as the company's constrained float faces intense short interest pressure.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors digest a massive new 270 million dollar cloud infrastructure deal involving Nvidia Blackwell chips, driving significant chatter about its transition into an AI-focused hyperscaler. The community is actively debating the impact of the Northern Data acquisition and record-high short interest, with many anticipating a major squeeze as the company builds out its data center capacity.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is experiencing significant trading activity as market participants closely monitor its role in the critical AI infrastructure buildout. The community remains divided, with some investors focusing on strong earnings and a massive backlog as catalysts for long-term growth, while others express concerns over valuation and the potential for increased volatility.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing intense market activity as investors weigh its pivot toward physical AI and QNX software against broader tech sector volatility. The community remains deeply divided, with long-term bulls highlighting institutional accumulation and QNX integration as a catalyst for growth, while critics argue current price swings reflect speculative overvaluation.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing heightened investor interest and increased volatility following the launch of an aggressive $250 billion U.S. connectivity infrastructure investment plan. The community is actively debating the stock's long-term value and dividend reliability against the backdrop of broader sector consolidation and intense competition from satellite-based rivals.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing a surge in institutional accumulation and community optimism, driven by promising clinical data, a shrinking float, and high expectations for upcoming BLA submissions. The community is actively discussing the potential for a transformative oncology buyout, with investors highlighting institutional confidence, significant short interest, and upcoming catalysts as key drivers for near-term momentum.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is surging as market sentiment shifts toward its role as a critical infrastructure provider for Physical AI, robotics, and autonomous systems following its recent collaboration with ARGUS Interception and positive analyst coverage. Investors are focused on the adoption of its new REV8 digital lidar, which integrates native color sensing, positioning the company as a key perception player as industrial and defense automation scales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cellectis (CLLS) to Release Quarterly Earnings on Monday

Cellectis (NASDAQ:CLLS) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-cellectis-sa-stock...

Cellectis (NASDAQ:CLLS) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?

Cellectis (NASDAQ:CLLS) Stock Price Crosses Below 200 Day Moving Average - Here's What Happened...

Cellectis (NASDAQ:CLLS) Shares Pass Below 200-Day Moving Average   - Time to Sell?

Cellectis (NASDAQ:CLLS) Stock Price Passes Below 200 Day Moving Average - Should You Sell...

Cellectis (NASDAQ:CLLS) Given Market Outperform Rating at Citizens Jmp

Citizens Jmp reiterated a "market outperform" rating and issued a $8.00 price objective on shares of Cellectis in a research note on Tuesday...

Cellectis S.A. (NASDAQ:CLLS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cellectis S.A. (NASDAQ:CLLS - Get Free Report) have been given an average rating of "Moderate Buy" by the five ratings firms that are presently covering the stock, Marketbeat Ratings...

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday

Cellectis shares fell after Allogene cited a favorable arbitration ruling confirming control of cema-cel and outlining key CAR-T milestones.read more...

Cellectis (NASDAQ:CLLS) Share Price Crosses Above Fifty Day Moving Average - Here's Why

Cellectis (NASDAQ:CLLS) Stock Passes Above Fifty Day Moving Average - Should You Sell...

Why Cellectis Stock Is Trading Higher Today

Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.read more...

Cellectis (NASDAQ:CLLS) Shares Cross Above Fifty Day Moving Average - Should You Sell?

Cellectis (NASDAQ:CLLS) Stock Crosses Above 50 Day Moving Average - Here's Why...

Cellectis (NASDAQ:CLLS) Posts Earnings Results, Beats Estimates By $0.11 EPS

Cellectis (NASDAQ:CLLS - Get Free Report) posted its quarterly earnings data on Friday. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus...

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

CLLSCellectis

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLLS News